The 2011 Leading Life Science Intermediates Companies Financial Analyses

October 2010 | 105 pages | ID: L9319070855EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

Each company’s analysis provides:

• Sales and operating profit by division, product line, geographic region and country.
• Five-year sales and profit performance.

The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 105 pages and 78 tables